Case Name: AMGEN INC., Plaintiff-Appellee, v. HOECHST MARION ROUSSEL, INC. (now known as Aventis Pharmaceuticals Inc.) and Transkaryotic Therapies, Inc., Defendants-Appellants
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2001-12-10
Citations: 26 F. App'x 923
Docket Number: No. 02-1074
Parties: AMGEN INC., Plaintiff-Appellee, v. HOECHST MARION ROUSSEL, INC. (now known as Aventis Pharmaceuticals Inc.) and Transkaryotic Therapies, Inc., Defendants-Appellants.
Judges: 
Reporter: West's Federal Appendix
Volume: 26
Pages: 923–923

Head Matter:
AMGEN INC., Plaintiff-Appellee, v. HOECHST MARION ROUSSEL, INC. (now known as Aventis Pharmaceuticals Inc.) and Transkaryotic Therapies, Inc., Defendants-Appellants.
No. 02-1074.
United States Court of Appeals, Federal Circuit.
Dec. 10, 2001.

Opinion:
ORDER
Pursuant to this court's November 30, 2001, order in 01-1191, -1218, Amgen Inc. v. Hoechst Marion Roussel, Inc., this appeal is dismissed sua sponte.